癌症免疫疗法的新免疫细胞参与者
Aurore Fenis1,2, Olivier Demaria1, Laurent Gauthier1
1Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.
Nature reviews. Immunology
|January 25, 2024
概括
最近的免疫疗法进展包括针对血液癌症的T细胞参与剂. 新分子和其他针对免疫细胞的药物旨在在各种癌症类型中获得更广泛的疗效和安全性.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 在癌症免疫疗法方面取得了显著进展,特别是在血液恶性瘤的T细胞参与剂方面.
- 在优化药物剂量,克服耐药性和提高针对T细胞向疗法的实体瘤疗效方面,仍然存在挑战.
研究的目的:
- 解决当前针对T细胞的癌症治疗方法的局限性.
- 探索新的免疫治疗策略,以改善不同类型癌症患者的治疗结果.
主要方法:
- 开发新一代针对T细胞的分子.
- 检查那些能影响其他免疫细胞的病原体,如自然杀手细胞 (NK) 和骨髓状细胞.
主要成果:
- 新的针对T细胞的分子显示出提高有效性和改善安全性概况的潜力.
- 免疫细胞参与剂在向更广泛的癌症频谱方面表现有前途.
结论:
- 下一代T细胞向疗法为癌症免疫疗法的现有挑战提供了潜在的解决方案.
- 吸引多种免疫细胞扩大了治疗各种恶性瘤的治疗范围,包括固体瘤.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
760
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
778
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Cytotoxic T Cells-mediated Immune Response
917
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
T Cell Activation and Clonal Selection
735
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
735
